UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act...
Orphan Programs, Clinical Data, Large Market Potential Filed by Celladon Corporation Pursuant to Rule 425...
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Celladon Corporation...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.